Biofarm (FRA:H3D) Cyclically Adjusted PB Ratio: (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:H3D Biofarm SA FRA:H3D
70 GF Score
Price €0.24
GF Value €0.15
! 5 Warning Signs
View Full Analysis

What is Biofarm Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biofarm  (FRA:H3D) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Biofarm Cyclically Adjusted PB Ratio Related Terms


Biofarm Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Biofarm's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofarm Cyclically Adjusted PB Ratio Chart

Biofarm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.87 1.87 2.31 2.11 2.15

Biofarm Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.92 2.21 2.21 2.15 3.09

FRA:H3D vs ZTS, UTHR, VTRS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biofarm's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofarm Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofarm's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biofarm's Cyclically Adjusted PB Ratio falls into.


FRA:H3D
70GF Score
Biofarm SA FRA:H3D
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biofarm Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biofarm's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Biofarm's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.112/330.2130*330.2130
=0.112

Current CPI (Mar. 2026) = 330.2130.

Biofarm Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.035 241.018 0.048
201609 0.037 241.428 0.051
201612 0.038 241.432 0.052
201703 0.040 243.801 0.054
201706 0.039 244.955 0.053
201709 0.041 246.819 0.055
201712 0.042 246.524 0.056
201803 0.044 249.554 0.058
201806 0.043 251.989 0.056
201809 0.045 252.439 0.059
201812 0.044 251.233 0.058
201903 0.047 254.202 0.061
201906 0.047 256.143 0.061
201909 0.050 256.759 0.064
201912 0.050 256.974 0.064
202003 0.053 258.115 0.068
202006 0.052 257.797 0.067
202009 0.055 260.280 0.070
202012 0.056 260.474 0.071
202103 0.061 264.877 0.076
202106 0.059 271.696 0.072
202109 0.063 274.310 0.076
202112 0.064 278.802 0.076
202203 0.070 287.504 0.080
202206 0.068 296.311 0.076
202209 0.073 296.808 0.081
202212 0.074 296.797 0.082
202303 0.080 301.836 0.088
202306 0.078 305.109 0.084
202309 0.081 307.789 0.087
202312 0.084 306.746 0.090
202403 0.088 312.332 0.093
202406 0.086 314.175 0.090
202409 0.092 315.301 0.096
202412 0.093 315.605 0.097
202503 0.099 319.799 0.102
202506 0.096 322.561 0.098
202509 0.104 324.800 0.106
202512 0.106 324.054 0.108
202603 0.112 330.213 0.112

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Biofarm (FRA:H3D) Overvalued in 2026?

Based on GuruFocus' analysis, Biofarm stock appears to be overvalued. The current stock price of €0.24 is trading 56.7% above its estimated GF Value™ of €0.15.

Key valuation signals for FRA:H3D:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €0.15 vs. price of €0.24 (56.7% above fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the FRA:H3D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biofarm Business Description

Other Exchanges BIO:Romania
Address 99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.
70GF Score

Get the complete analysis for FRA:H3D

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.24
Price
€0.15
GF Value